These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Anti-inflammatory effect of taurocholate on TNBS-induced ulcerative colitis in mice. Yang Y; He J; Suo Y; Lv L; Wang J; Huo C; Zheng Z; Wang Z; Li J; Sun W; Zhang Y Biomed Pharmacother; 2016 Jul; 81():424-430. PubMed ID: 27261622 [TBL] [Abstract][Full Text] [Related]
46. Inhibitory effect of β-sitosterol on TNBS-induced colitis in mice. Lee IA; Kim EJ; Kim DH Planta Med; 2012 Jun; 78(9):896-8. PubMed ID: 22538477 [TBL] [Abstract][Full Text] [Related]
47. NOX1/NADPH Oxidase Expressed in Colonic Macrophages Contributes to the Pathogenesis of Colonic Inflammation in Trinitrobenzene Sulfonic Acid-Induced Murine Colitis. Yokota H; Tsuzuki A; Shimada Y; Imai A; Utsumi D; Tsukahara T; Matsumoto M; Amagase K; Iwata K; Nakamura A; Yabe-Nishimura C; Kato S J Pharmacol Exp Ther; 2017 Jan; 360(1):192-200. PubMed ID: 27754929 [TBL] [Abstract][Full Text] [Related]
48. Alpha-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats. Kolgazi M; Jahovic N; Yüksel M; Ercan F; Alican I J Gastroenterol Hepatol; 2007 Nov; 22(11):1859-65. PubMed ID: 17914960 [TBL] [Abstract][Full Text] [Related]
49. Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis. Guan Q; Ma Y; Hillman CL; Qing G; Ma AG; Weiss CR; Zhou G; Bai A; Warrington RJ; Bernstein CN; Peng Z Mol Med; 2011; 17(7-8):646-56. PubMed ID: 21424108 [TBL] [Abstract][Full Text] [Related]
50. Amelioration of trinitrobenzene sulfonic acid-induced colitis in mice by liquiritigenin. Min JK; Lee CH; Jang SE; Park JW; Lim SJ; Kim DH; Bae H; Kim HJ; Cha JM J Gastroenterol Hepatol; 2015 May; 30(5):858-65. PubMed ID: 25311527 [TBL] [Abstract][Full Text] [Related]
51. Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis. Clemente TR; Dos Santos AN; Sturaro JN; Gotardo EM; de Oliveira CC; Acedo SC; Caria CR; Pedrazzoli J; Ribeiro ML; Gambero A Scand J Gastroenterol; 2012 Sep; 47(8-9):943-50. PubMed ID: 22630819 [TBL] [Abstract][Full Text] [Related]
52. Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis. Boirivant M; Fuss IJ; Ferroni L; De Pascale M; Strober W J Immunol; 2001 Mar; 166(5):3522-32. PubMed ID: 11207312 [TBL] [Abstract][Full Text] [Related]
54. Semi-bionic extraction of compound turmeric protects against dextran sulfate sodium-induced acute enteritis in rats. Wang R; Wu G; Du L; Shao J; Liu F; Yang Z; Liu D; Wei Y J Ethnopharmacol; 2016 Aug; 190():288-300. PubMed ID: 27286916 [TBL] [Abstract][Full Text] [Related]
55. PARP inhibition reduces acute colonic inflammation in rats. Sánchez-Fidalgo S; Villegas I; Martín A; Sánchez-Hidalgo M; Alarcón de la Lastra C Eur J Pharmacol; 2007 Jun; 563(1-3):216-23. PubMed ID: 17374531 [TBL] [Abstract][Full Text] [Related]
56. Poncirin and its metabolite ponciretin attenuate colitis in mice by inhibiting LPS binding on TLR4 of macrophages and correcting Th17/Treg imbalance. Kang GD; Kim DH J Ethnopharmacol; 2016 Aug; 189():175-85. PubMed ID: 27224242 [TBL] [Abstract][Full Text] [Related]
57. GPR120, a potential therapeutic target for experimental colitis in IL-10 deficient mice. Zhao J; Wang H; Shi P; Wang W; Sun Y Oncotarget; 2017 Jan; 8(5):8397-8405. PubMed ID: 28039475 [TBL] [Abstract][Full Text] [Related]
58. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375 [TBL] [Abstract][Full Text] [Related]
59. Anticolitis activity of Chinese herbal formula yupingfeng powder via regulating colonic enterochromaffin cells and serotonin. Zang KH; Rao Z; Zhang GQ; Qin HY Indian J Pharmacol; 2015; 47(6):632-7. PubMed ID: 26729955 [TBL] [Abstract][Full Text] [Related]
60. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease. Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]